AstraZeneca Opens Plant in China.(pharmaceutical manufacturing plant near Shanghai)(Brief Article)

Chemical Market Reporter, May, 2001

IN ITS LARGEST investment in China to date, AstraZeneca PLC has opened a new $100 million pharmaceutical manufacturing plant in Wuxi New District, near Shanghai. The plant will manufacture the stomach acid treatment Losec/Prilosec/Omepral (omeprazole), the heart disease drug Piendil (felodipine), and asthma treatments.

Losec is currently manufactured in a Swedish facility with total capacity of seven billion tablets. Construction of the new plant began in 1998. Estimated annual production capacity will be 1.5 billion tablets, 70 million capsules, 2.5 million bottles of oral solutions, 4 million bottles of dose-aerosols/sprays, and 6 million vials of sterile products. "There are Western manufacturers with plants there [in China], but this is one of...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement